Health

YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval From Philippines FDA

GAITHERSBURG, Md., June 1, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseas...

2023-06-01 20:30 2643

Aravax doses first patient in Phase 2 peanut allergy clinical trials

MELBOURNE, Australia, June 1, 2023 /PRNewswire/ -- The first patient has been dosed in a Phase 2 study (AVX-201) being run by biotechnology company Aravax, which is developing the novel therapy PVX108 for the safe and convenient treatment of peanut allergy. The study is being conducted under a U....

2023-06-01 20:00 1757

BIORCHESTRA Invited to Present Update on Central Nervous System Lead Program (BMD-001) and IV-Formulated siRNA Data at BIO2023 International Conference

* Presentation:"Successfully Achieving Intravenous (IV)-formulated RNA Delivery to the Brain, Evidence of Efficacy" scheduled for June 08, 2023, 12:00 p.m. ET, Room 104A * Pioneering IV-formulated inert drug delivery platform targeting neurodegenerative diseases * Lead program (BMD-001) adv...

2023-06-01 20:00 2005

Seegene Obtains IVDR Certification for 30 Diagnostic Assays

* Seegene certifies diagnostic assays for digestive, respiratory, women's diseases, and human papillomavirus to meet IVDR requirements * New regulation sets improved standards to ensure higher level of quality, safety, and reliability SEOUL, South Korea, June 1, 2023 /PRNewswire/ -- Seegene I...

2023-06-01 19:00 1895

Kombucha Continues to Trend! TCI Received the Golden Award at the Geneva International Exhibition of Inventions

TAIPEI, June 1, 2023 /PRNewswire/ -- Beauty and anti-aging have become a global trend. InMay 2023, TCI (tt 8436) won gold, silver, and a bronze award at the Geneva International Exhibition of Inventions for its three exclusive ingredient formulas: Probio-Kombu black tea, Mango Unripe Fruit Extrac...

2023-06-01 18:06 1954

Xinhua Silk Road: Activity to promote TCM cultural exchanges and cooperation between China and Luxembourg completes success

BEIJING, June 1, 2023 /PRNewswire/ -- An activity to promote traditional Chinese medicine (TCM) cultural exchanges and cooperation betweenChina and Luxembourg held recently at the Luxembourg Embassy in China achieved a complete success. A tea...

2023-06-01 17:37 1862

Xinhua Silk Road: Global co-op highlighted in tour of Chinese herbs firm to Indonesian embassy in China

BEIJING, June 1, 2023 /PRNewswire/ -- A tour to the Indonesian embassy in China by representatives from Zhejiang Longevity Valley Botanical Co., Ltd. cast a spot light on the rising importance of cooperation and communication in the era of globalization.

2023-06-01 17:35 2080

Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe

VIENNA, June 1, 2023 /PRNewswire/ -- Croma-Pharma, a global player and challenger in the dynamically growing, minimally invasive aesthetics market, announces that it will launch Pliaglis®, a topical local anaesthetic for superficial dermatological procedures, in its European core markets includin...

2023-06-01 17:18 3173

WuXi Biologics to Increase Manufacturing Capacity in Germany

-  In response to global clients' increasing demand for contract manufacturing services, WuXi Biologics is expanding its capacity for drug substance and drug product inGermany -  The investment promotes the creation of additional high-skilled jobs -  As part of WuXi Biologics' global manufacturi...

2023-06-01 16:49 3209

Soul App Lights up the Day for People with Visual Impairments through the "Trainee Melancholy Healer" Activity

SHANGHAI, June 1, 2023 /PRNewswire/ -- Beyond the stereotype of a massage therapist, what other career possibilities does life hold for the visually challenged? On the evening of 21st May, to celebrate China's 33rd national day of assisting people with disabilities, the social media platform Soul...

2023-06-01 16:01 2034

CRScube Expands Services in Europe with New Clinical Study Collaborations

SEOUL, South Korea, June 1, 2023 /PRNewswire/ -- CRScube, a leading provider of eClinical solutions, today announced its recent collaborations with two European companies. These new collaborations aim to expand the reach of CRScube's innovative eClinical solutions in the European clinical trial ...

2023-06-01 16:00 2235

Mediso installs 100% cryogen-free 7T MRI at the University of Milano-Bicocca, Italy

BUDAPEST, Hungary, June 1, 2023 /PRNewswire/ -- Mediso Medical Imaging Systems recently installed a state-of-the-art 7T MRI at the University of Milano-Bicocca. The nanoScan® MRI 7T installed is equipped with a state-of-the-art cryogen-free superconducting magnet. Uniquely o...

2023-06-01 16:00 1896

New Genea Fertility Clinic to Open in North Melbourne

MELBOURNE, Australia , June 1, 2023 /PRNewswire/ -- Genea Fertility is pleased to announce the expansion of its services inVictoria with the opening of a new clinic inNorth Melbourne. Genea Fertility is opening a new clinic in North Melbo...

2023-06-01 15:58 2689

GenesisCare Files for Voluntary Reorganisation to Advance Business Transformation

Company to Obtain US$200 Million in New Financing to Support Ordinary Course Business Operations Globally All GenesisCare Businesses Show Strong Momentum and Growth Potential Company to Pursue Separation of U.S. Business While U.S. Management Implements Turnaround Strategy SYDNEY, June 1, 2023...

2023-06-01 14:09 2251

Antengene Announces XPOVIO® plus Bortezomib and Dexamethasone Included for Reimbursement by the PBS in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma

-  XPOVIO® (selinexor) is the first and only selective inhibitor of nuclear export (SINE) inhibitor approved by the Therapeutic Goods Administration (TGA) ofAustralia for patients with relapsed and/or refractory multiple myeloma (R/R MM) and in triple class refractory R/R MM. -  This inclusion b...

2023-06-01 10:09 2982

CBC GROUP RELEASES 2022 ESG REPORT

Guided by the firm's commitment to drive positive and meaningful impact while delivering better healthcare for all SINGAPORE, May 31, 2023 /PRNewswire/ -- CBC Group ("CBC"), Asia's largest healthcare-dedicated investment firm, today published its Environmental, Social and Governance ("ESG")...

2023-06-01 10:00 2162

Xinhua Silk Road: Chinese Lingzhi brand Longevity Valley promotes inheritance of a century-old national treasure to Brunei foreign envoys

BEIJING, May 31, 2023 /PRNewswire/ -- A delegation of the renowned Chinese Lingzhi brand, Zhejiang Longevity Valley Botanical Co., Ltd, recently visited the Embassy ofBrunei Darussalam in China to showcase Chinese traditional culture and wisdom of health philosophy embedded in the brand toBrunei....

2023-06-01 09:47 2015

Mediso installs 100% cryogen-free 7T MRI at the University of Milano-Bicocca, Italy

BUDAPEST, Hungary, June 1, 2023 /PRNewswire/ -- Mediso Medical Imaging Systems recently installed a state-of-the-art 7T MRI at the University of Milano-Bicocca. The nanoScan® MRI 7T installed is equipped with a state-of-the-art cryogen-free superconducting magnet. Uniquely o...

2023-06-01 09:00 2389

National Comprehensive Cancer Network Joins Collaboration to Improve Standards in Cancer Care for Vietnam

United States-based NCCN representatives visit Hanoi, Vietnam to work with local experts to improve quality-of-life for patients with cancer throughout the country. PHILADELPHIA and HANOI, Vietnam, June 1, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—a not-for-profit a...

2023-06-01 09:00 2949

Brii Biosciences Announces First Subject Dosed in Phase 1 Clinical Trial of BRII-297, Long-Acting Injectable for the Treatment of Anxiety and Depressive Disorders

BRII-297, a first-of-its-kind treatment option for anxiety and depressive disorders, has the potential to enable greater therapeutic adherence and convenience for patients DURHAM, N.C. and BEIJING, June 1, 2023 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or...

2023-06-01 08:00 2494
1 ... 155156157158159160161 ... 822